Researchers studying brain microvascular endothelial cells report that a deficiency in the cytoskeletal protein non-muscle myosin IIA triggers neuroinflammation during aging by disrupting autophagic degradation and causing the accumulation of vascular cell adhesion molecule-1.
NMIIA Decline Drives Endothelial Dysfunction
Endothelial cell dysfunction acts as a primary catalyst for neuroinflammation. While non-muscle myosin IIA (NMIIA) plays an established role in cerebrovascular pathology, its contribution remained unclear. Investigations reveal that NMIIA expression declines in brain microvascular endothelial cells as the organism ages.
Laboratory findings utilizing in vitro knockdown techniques and endothelial-specific conditional knockout mouse models demonstrate that losing NMIIA selectively upregulates VCAM-1 protein. This alteration occurs without affecting VCAM-1 messenger RNA or other classical inflammatory mediators.
Defective Autophagy Blocks Protein Degradation
Mechanistically, the loss of NMIIA disrupts autophagic flux by impeding autophagosome-lysosome fusion. This inhibition prevents normal autophagic degradation, driving the subsequent accumulation of VCAM-1.
Proteomic screening and biochemical assays establish Caveolin-1 as a direct binding partner of NMIIA. NMIIA deficiency promotes the redistribution of the autophagy-related protein ATG5 into Caveolin-1-enriched lipid raft domains, a cellular change known to suppress the initiation of autophagy.
Pharmacological experiments using rapamycin partially relieved VCAM-1 accumulation. This suggests that stimulating autophagy helps rescue the defect.
The incomplete recovery indicates that the underlying disruption operates upstream or during vesicle maturation. Assays tracking protein stability through cycloheximide chase experiments confirmed that VCAM-1 decayed more slowly following NMIIA silencing.
Memory Loss Follows Microglial Activation
Soluble VCAM-1 released from NMIIA-deficient endothelial cells promotes the pro-inflammatory polarization of microglia and induces neuronal apoptosis in laboratory settings.
In living subjects, endothelial-specific NMIIA knockout mice exhibit pronounced microglial activation alongside impaired hippocampal neurogenesis, neuronal loss, and significant deficits in learning and memory behaviors. These in vivo observations validate the pathway’s physiological relevance. By connecting vascular cytoskeletal regulation directly to neuroimmune consequences, the published analysis defines a distinct regulatory axis that bridges molecular protein turnover with system-level cognitive decline.